Cargando…

Central venous access devices implantation in children with severe hemophilia a: data from the children comprehensive care center of China

OBJECTIVES: To report the perioperative management experience of central venous access devices (CVAD) in Chinese children with severe hemophilia A (SHA) in China. METHODS: This retrospective study included SHA children who underwent Port-A-Cath or peripherally inserted central catheter (PICC) implan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Qian, Wang, Chunli, Cheng, Wei, Zhen, Yingzi, Ding, Yaguang, Liu, Guoqing, Yao, Wanru, Chen, Zhenping, Li, Zhiqiang, Wu, Runhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976301/ https://www.ncbi.nlm.nih.gov/pubmed/36873489 http://dx.doi.org/10.1016/j.heliyon.2023.e13666

Ejemplares similares

Real-world experience of emicizumab prophylaxis in young children with hemophilia A: retrospective data from China
por: Liu, Guoqing, et al.
Publicado: (2022)

Low‐dose immune tolerance induction in children with severe hemophilia A with high‐titer inhibitors: Type of factor 8 mutation and outcomes
por: Sun, Jie, et al.
Publicado: (2022)

Low‐dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors
por: Li, Zekun, et al.
Publicado: (2021)

PK‐tailored tertiary prophylaxis in patients with severe hemophilia A at Beijing Children's Hospital
por: Li, Peijing, et al.
Publicado: (2019)

Pharmacokinetic variability of factor VIII concentrates in Chinese pediatric patients with moderate or severe hemophilia A
por: Chen, Zhenping, et al.
Publicado: (2021)

Low‐dose immune tolerance induction for children with hemophilia A with poor‐risk high‐titer inhibitors: A pilot study in China
por: Li, Zekun, et al.
Publicado: (2019)

Enhanced pharmacokinetics and reduced bleeds in boys with hemophilia A after switching to Kovaltry from other standard half‐life factor VIII concentrates
por: Huang, Kun, et al.
Publicado: (2022)

Development and desensitization therapy of high-response factor VIII inhibitors with severe allergic reaction in a moderate hemophilia A patient
por: Liu, Guoqing, et al.
Publicado: (2021)

Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low‐dose secondary prophylaxis study
por: Wu, Runhui, et al.
Publicado: (2021)

F8 gene mutation spectrum in severe hemophilia A with inhibitors: A large cohort data analysis from a single center in China
por: Sun, Jie, et al.
Publicado: (2022)

Exploration of the minimum necessary FVIII level at different physical activity levels in pediatric patients with hemophilia A
por: Ai, Di, et al.
Publicado: (2022)

Insertion of Totally Implantable Central Venous Access Devices by Surgeons
por: An, Hyeonjun, et al.
Publicado: (2015)

Factors affecting mechanical complications of central venous access devices in children
por: Zhang, Jessica J., et al.
Publicado: (2022)

F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B
por: Liu, Guoqing, et al.
Publicado: (2023)

Experiences of children with central venous access devices: a mixed-methods study
por: Ullman, Amanda J., et al.
Publicado: (2022)

Unusual Venous Access for Device Implantation
por: Al-Sadawi, Mohammed, et al.
Publicado: (2019)

Pyoderma gangrenosum after totally implanted central venous access device insertion
por: Inan, Ihsan, et al.
Publicado: (2008)

Commentary on "Insertion of Totally Implantable Central Venous Access Devices by Surgeons" - What Is the Role of Surgeons When Implanting a Totally Implantable Venous Access Device to Prevent Immediate Complications?
por: Toro, Adriana, et al.
Publicado: (2015)

Recurrent Septic Pulmonary Embolism Related to an Implanted Central Venous Access Port Device
por: Hong, Goohyeon, et al.
Publicado: (2018)

Femoral Access for Central Venous Port System Implantation
por: Cherkashin, Mikhail, et al.
Publicado: (2018)

Rupture of totally implantable central venous access devices (Intraports) in patients with cancer: report of four cases
por: Filippou, Dimitrios K, et al.
Publicado: (2004)

Stuck fragment of totally implantable central venous access ports during removal: risk factor analysis in children
por: Jung, Hanna, et al.
Publicado: (2021)

Intrapulmonal dislocation of a totally implantable venous access device
por: Hackert, Thilo, et al.
Publicado: (2005)

Utilization and Complications of Central Venous Access Devices in Oncology Patients
por: Akhtar, Narmeen, et al.
Publicado: (2021)

User-centered design of central venous access device documentation
por: Kandaswamy, Swaminathan, et al.
Publicado: (2022)

Pediatric central venous access devices: practice, performance, and costs
por: Ullman, Amanda J., et al.
Publicado: (2022)

T2 mapping in the quantitative evaluation of articular cartilage changes in children with hemophilia: A pilot study
por: Zhang, Ningning, et al.
Publicado: (2019)

Individualised prophylaxis based on personalised target trough FVIII level optimised clinical outcomes in paediatric patients with severe haemophilia A
por: Huang, Kun, et al.
Publicado: (2022)

Impact of central venous port implantation method and access choice on outcomes
por: Erdemir, Ayhan, et al.
Publicado: (2023)

Fracture and embolization of an implantable venous access device in patient with atrial septal defect
por: Syltern, Julie, et al.
Publicado: (2020)

Comprehensive management of hemophilia /
Publicado: (1976)

Central venous catheters in children and neonates (Part 3) – Access via the femoral vein
por: Trieschmann, U, et al.
Publicado: (2008)

Development of central venous access device‐associated skin impairment assessment instrument
por: Liu, Min, et al.
Publicado: (2022)

Application of transesophageal echocardiography for localization in totally implantable venous access port implantation through subclavian approach in children
por: Yang, Shujun, et al.
Publicado: (2020)

Adult ‘PICC’ Device May be Used as a Tunnelled Central Venous Catheter in Children
por: Lawson, Brooke T., et al.
Publicado: (2018)

The Malposition of Central Venous Catheters in Children
por: Dzierzega, Maria, et al.
Publicado: (2014)

Implantation of venous access devices under local anesthesia: patients’ satisfaction with oral lorazepam
por: Chang, De-Hua, et al.
Publicado: (2015)

Brachial Approach As an Alternative Technique of Fibrin Sheath Removal for Implanted Venous Access Devices
por: Sotiriadis, Charalampos, et al.
Publicado: (2017)

Usefulness of Percutaneous Puncture in Insertion of Totally Implantable Venous Access Devices in Pediatric Patients
por: Choi, Jung Sik, et al.
Publicado: (2017)

Implantable Venous Access Devices in Pediatric Malignancies – Institutional Experience in a Developing Nation
por: Sundaram, Jegadeesh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5b70ctfm8ijffu7m6cea3fa7ei